Literature DB >> 9048350

Temporal induction of clusterin in cisplatin nephrotoxicity.

J R Silkensen1, A Agarwal, K A Nath, J C Manivel, M E Rosenberg.   

Abstract

Clusterin is a ubiquitous glycoprotein induced in many organs, including the kidney, at times of tissue injury and/or remodeling. It is speculated in this study that clusterin preserves cell interactions that are otherwise perturbed by renal insults. The purpose of this study was to examine clusterin expression after cisplatin nephrotoxicity, a model characterized by a delayed time course of injury and a well-defined site of that injury (proximal tubule). Sprague-Dawley rats were treated with intravenous cisplatin (6 mg/kg) or vehicle. Serum creatinine concentrations were measured and kidneys harvested at 1, 2, and 5 days. Marked induction of clusterin mRNA was seen only at 5 days, a time when serum creatinine concentration was the highest. Histology of kidney tissue 5 days after cisplatin administration revealed marked tubular necrosis localized to the outer stripe of the outer medulla, a region rich in proximal tubules. Immunohistochemistry and in situ hybridization at 5 days demonstrated clusterin primarily in the inner stripe of the outer medulla. In conclusion, expression of clusterin follows renal injury with cisplatin at a time corresponding to the morphologic evidence of tubular necrosis and cell detachment; quite surprisingly, such expression occurs at a site distant from the primary injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048350     DOI: 10.1681/ASN.V82302

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  6 in total

1.  A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function.

Authors:  Josef S Ozer; Frank Dieterle; Sean Troth; Elias Perentes; André Cordier; Pablo Verdes; Frank Staedtler; Andreas Mahl; Olivier Grenet; Daniel R Roth; Daniel Wahl; François Legay; Daniel Holder; Zoltan Erdos; Katerina Vlasakova; Hong Jin; Yan Yu; Nagaraja Muniappa; Tom Forest; Holly K Clouse; Spencer Reynolds; Wendy J Bailey; Douglas T Thudium; Michael J Topper; Thomas R Skopek; Joseph F Sina; Warren E Glaab; Jacky Vonderscher; Gérard Maurer; Salah-Dine Chibout; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

2.  Calcium oxalate calculi-induced clusterin expression in kidney.

Authors:  Jin-Yi Li; Junjiang Liu; Junyi Jiang; Chris Pumill; Cordelia Elaiho; Yunxia Zhang; Shoubin Li; Tie Zhou
Journal:  Urolithiasis       Date:  2015-05-21       Impact factor: 3.436

Review 3.  Biomarkers of nephrotoxic acute kidney injury.

Authors:  Michael A Ferguson; Vishal S Vaidya; Joseph V Bonventre
Journal:  Toxicology       Date:  2008-01-04       Impact factor: 4.221

Review 4.  Biomarkers of acute kidney injury.

Authors:  Vishal S Vaidya; Michael A Ferguson; Joseph V Bonventre
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

5.  Identification of putative gene based markers of renal toxicity.

Authors:  Rupesh P Amin; Alison E Vickers; Frank Sistare; Karol L Thompson; Richard J Roman; Michael Lawton; Jeffrey Kramer; Hisham K Hamadeh; Jennifer Collins; Sherry Grissom; Lee Bennett; C Jeffrey Tucker; Stacie Wild; Clive Kind; Victor Oreffo; John W Davis; Sandra Curtiss; Jorge M Naciff; Michael Cunningham; Raymond Tennant; James Stevens; Bruce Car; Timothy A Bertram; Cynthia A Afshari
Journal:  Environ Health Perspect       Date:  2004-03       Impact factor: 9.031

6.  Electrolytes supplementation can decrease the risk of nephrotoxicity in patients with solid tumors undergoing chemotherapy with cisplatin.

Authors:  Omary M S Minzi; Tatu E Lyimo; Francis F Furia; Alphonce I Marealle; Manase Kilonzi; George M Bwire; Christina Malichewe
Journal:  BMC Pharmacol Toxicol       Date:  2020-09-23       Impact factor: 2.483

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.